Who is sponsoring NCT06983223?

NCT06983223 is sponsored by Liaquat University of Medical & Health Sciences.

What condition does NCT06983223 study?

NCT06983223 studies Vitamin B 12 Deficiency, Type 2 Diabetes Mellitus (T2DM).

What drugs are being tested in NCT06983223?

Interventions: Sucrosomial® Vitamin B12, Placebo (Oral).

What is the status of NCT06983223?

NCT06983223 is currently COMPLETED.

Last reviewed 2025-12-10 · How we verify

Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients

NCT06983223 NA COMPLETED

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effectiveness of Sucrosomial® Vitamin B12 supplementation in the management of vitamin B12 deficiency among metformin-treated Type 2 Diabetes Mellitus (T2DM) patients. The study will compare the impact of daily Sucrosomial® B12 (1,000 mcg) versus placebo on serum vitamin B12 levels, Holo-Transcobalamin II (HoloTCII), and Transcobalamin I (TCI) levels over a 4-week period. Secondary outcomes include assessment of safety, tolerability, and glycemic control (HbA1c). Fifty participants will be randomly assigned to either the Sucrosomial® B12 or placebo group.

Details

Lead sponsor	Liaquat University of Medical & Health Sciences
Phase	NA
Status	COMPLETED
Enrolment	50
Start date	Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Vitamin B 12 Deficiency
Type 2 Diabetes Mellitus (T2DM)

Interventions

Sucrosomial® Vitamin B12
Placebo (Oral)

Countries

Pakistan